摘要
新型冠状病毒肺炎(COVID-19)是由新型冠状病毒(SARS-CoV-2)引起的一种具有发病率、致死率极高的新型呼吸系统传染病。由于SARS-CoV-2本身的特异性,其突变率较高,目前已出现一系列不同的SARS-CoV-2变异株,使COVID-19疫情一直反复。近日,世界卫生组织(WHO)公布了新变异株“奥密克戎”(Omicron,B.1.1.529),并宣称该变异株可能具有较强的传染性、较高的抗体耐受性及疫苗耐受性。本文就“奥密克戎”变异株的最新研究进展作一简要综述。
Coronavirus disease 2019(COVID-19)is a novel respiratory infectious disease with high incidence and mortality rate caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).Due to the specificity of the novel coronavirus SARS-CoV-2 itself and its high mutation rate,a series of different novel coronavirus variants have appeared,which has led to repeated outbreaks of COVID-19.Recently,the World Health Organization(WHO)has announced a new variant"Omicron"(Omicron,B.1.1.529),and declared that the mutant strain may be highly infectious,antibody tolerant and highly resistant to vaccines.This article briefly reviews the latest research progress of the"Omicron"variants.
作者
高春
冯富娟
江晶晶
姚晓文
于晓辉
张久聪
GAO Chun;FENG Fu-juan;JIANG Jing-jing;YAO Xiao-wen;YU Xiao-hui;ZHANG Jiu-cong(School of Clinical Medicine,Gansu University of Chinese Medicine,Lanzhou 730000,China;Department of Gastroenterology,The 940 Hospital of Joint Logistic Support Force of PLA,Lanzhou 730050,China)
出处
《海南医学院学报》
CAS
2022年第7期481-485,共5页
Journal of Hainan Medical University
基金
第九四〇医院新冠肺炎应急医学科研项目(20yjky020)
火神山医院科研基金面上项目(HSS-217)。